SenesTech reports FY2025 revenue up 20% to $2.2M; net loss $6.4M; CEO transition started

SenesTech, Inc.

Full-year 2025 revenue $2.2M (+20% YoY); gross profit margin improved to 62.5% from 54.1%.
Net loss $6.4M vs $6.2M in 2024; adjusted EBITDA loss improved to $5.3M from $5.8M.
E-commerce revenue up 88% YoY; direct Amazon management transition cost ~$200K in Q4, expected to boost margins.
Field validation: Evolve deployment showed 79% decline in rat activity at one urban site within 5 months.
Board started CEO search after Joel Fruendt's retirement; Dr. Jamie Bechtel appointed Interim Executive Chair.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SenesTech, Inc. reported Full year ended December 31, 2025 results: net income $6.4 million.

Period: Full year ended December 31, 2025
Net income: $6.4 million
Result: reported results

Exact text from the filing

Revenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company’s overall e-commerce channels despite the impact associated with the Company’s transition to directly managing Amazon sales of Evolve ® Rat and Evolve Mouse.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SenesTech, Inc. reported Full year ended December 31, 2025 results: net income $6.4 million.

Period: Full year ended December 31, 2025
Net income: $6.4 million
Result: reported results

Exact text from the filing

Net loss for 2025 was $6.4 million compared to $6.2 million in 2024.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

SenesTech, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-017224

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.